| 000 | 01866nam a22003378a 4500 | ||
|---|---|---|---|
| 005 | 20250918165028.0 | ||
| 008 | 120814s2011 njua j b 001 0 eng | ||
| 020 |
_a9780470484074 _cRM373.01 |
||
| 039 | 9 |
_a201211011538 _bzainol _c201210050947 _drazalis _y08-14-2012 _zrazalis |
|
| 040 | _aUKM | ||
| 090 | _aQV744.A238 2011 9 | ||
| 090 |
_aQV744 _b.A238 2011 9 |
||
| 245 | 0 | 0 |
_aADMET for medicinal chemists : _ba practical guide / _cedited by Katya Tsaioun, Steven A. Kates. |
| 246 | 1 | 3 | _aAbsorption, distribution, metabolism, excretion, toxicity for medical chemists |
| 260 |
_aHoboken, N.J. : _bJohn Wiley & Sons, _c2011. |
||
| 300 |
_axiii, 498 p. : _bill. ; _c24 cm. |
||
| 505 | 0 | _aIn silico ADME/tox predictions / David Lagorce ... [et al.] -- Absorption and physicochemical properties of the NCE / Jon Selbo and Po-Chang Chiang -- ADME / Martin E. Dowty ... [et al.] -- Pharmacokinetics for medicinal chemists / Leo Kirkovsky and Anup Zutshi -- Cardiac toxicity / Ralf Kettenhofen and Silke Schwengberg -- Genetic toxicity : in vitro approaches for medicinal chemists / Richard M. Walmsley and David Elder -- Hepatic toxicity / Jinghai James Xu and Keith Hoffmaster -- In vivo toxicological considerations / John P. Devine Jr. --Pre-clinical candidate nomination and development / Nils Bergenhem -- Fragment-based drug design : considerations for good ADME properties / Haitao Ji. | |
| 650 | 2 | _aDrug Design. | |
| 650 | 2 | _aDrug Toxicity. | |
| 650 | 2 |
_aPharmaceutical Preparations _xchemistry. |
|
| 650 | 2 | _aPharmacokinetics. | |
| 700 | 1 | _aTsaioun, Katya. | |
| 700 | 1 |
_aKates, Steven A., _d1961- |
|
| 907 |
_a.b15452517 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV744.A238 2011 9 |
||
| 914 | _avtls003510554 | ||
| 990 | _azr | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _b2012-01-08 _cm _da _feng _gnju _y0 _z.b15452517 |
||
| 999 |
_c528553 _d528553 |
||